Leukocyte-Poor Platelet-Rich Plasma-Derived Growth Factors Enhance Human Fibroblast Proliferation In Vitro

Kyu-Cheol NOH; Xiao-Ning LIU; Zhong ZHUAN; Cheol-Jung YANG; Yong-Tae KIM; Geun-Woo LEE; Kyung-Ho CHOI; Kyung-Ok KIM.
Clinics in Orthopedic Surgery ; : 240-247, 2018.
Artículo en Inglés | WPRIM | ID: wpr-715556

Documentos relacionados

  1. The usefulness of platelet-rich plasma to manage skin wounds: A meta-analysis.
  2. Platelet-Rich Plasma, Bone Morphogenetic Protein, and Stem Cell Therapies.
  3. Efficacy of platelet-rich plasma for non-transfusion use: Overview of systematic reviews.
  4. Pure Platelet and Leukocyte-Platelet-Rich Plasma for Regenerative Medicine in Orthopedics-Time- and Preparation-Dependent Release of Growth Factors and Effects on Synovial Fibroblasts: A Comparative Analysis.
  5. Artificial dermis combined with negative pressure wound therapy and platelet-rich plasma to treat traumatic wounds: a retrospective study.
  6. Action of Platelet-Rich Plasma on In Vitro Cellular Bioactivity: More than Platelets.
  7. Hormesis mediates platelet-rich plasma and wound healing.
  8. Soluble factors differ in platelets derived from separate niches: a pilot study comparing the secretome of peripheral blood and bone marrow platelets.
  9. Platelet-Rich Plasma - a remedy present in every human being. History, functioning, and the benefits of therapy using it.
  10. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols.